INJ Price Struggles at $12.58 as Exchange Delistings Create Selling Pressure

Quick Take

• INJ currently trading at $12.58 (-1.79% in 24h)
• Injective’s RSI at 43.63 suggests neutral momentum with potential oversold conditions developing
• Major exchange delistings last week created significant selling pressure despite recent price stabilization

What’s Driving Injective Price Today?

The INJ price remains under pressure following last week’s regulatory turbulence that saw multiple major exchanges delist the token due to compliance concerns. On August 27th, these delistings triggered a sharp 22.22% single-day decline, creating substantial downward momentum that continues to influence trading sentiment.

However, recent price action shows signs of stabilization. After the initial shock, the INJ price found footing around $12.97 on August 31st, with technical indicators displaying neutral momentum. This stabilization suggests that the immediate selling pressure from the delisting news may be subsiding, though the broader regulatory environment continues to cast uncertainty over Injective’s near-term prospects.

The 24-hour trading volume of $10.4 million on Binance spot market indicates moderate interest from traders, though this remains below historical averages during more bullish periods. The regulatory overhang has clearly dampened institutional participation, creating a more retail-driven trading environment.

INJ Technical Analysis: Mixed Signals Emerge

Injective technical analysis reveals a complex picture with both bearish and bullish elements competing for dominance. The INJ RSI currently sits at 43.63, placing it in neutral territory but approaching oversold conditions that could signal a potential bounce.

The moving averages paint a concerning picture for bulls, with INJ price trading below all key shorter-term averages. Injective’s price sits below the SMA 7 ($13.00), SMA 20 ($13.77), and SMA 50 ($13.92), indicating sustained bearish pressure. However, the token remains above its SMA 200 at $11.81, suggesting the longer-term uptrend hasn’t been completely invalidated.

Injective’s MACD shows bearish momentum with a reading of -0.3281 and a negative histogram of -0.1954. This suggests that selling pressure continues to outweigh buying interest in the short term. The Stochastic indicators further confirm this weakness, with %K at 14.19 and %D at 8.68, both in deeply oversold territory.

Injective Price Levels: Key Support and Resistance

The Bollinger Bands analysis reveals critical insights about INJ’s current positioning. With Injective trading near the lower band at $12.00 and showing a %B position of 0.1642, the token is approaching oversold levels that historically have provided buying opportunities.

Injective support levels are clearly defined, with immediate support at $12.15 representing the 24-hour low. Should this level fail, the next major Injective support lies at $11.91, which aligns closely with the 200-day moving average. This confluence makes the $11.80-$11.90 zone particularly significant for determining INJ’s medium-term direction.

On the upside, INJ resistance appears formidable at $16.55, representing both immediate and strong resistance levels. The middle Bollinger Band at $13.77 serves as an intermediate target, coinciding with the SMA 20. For bulls to regain control, INJ price would need to reclaim the $13.00 level and subsequently challenge the $13.77 resistance zone.

The daily ATR of $1.07 suggests that traders should expect continued volatility, with potential daily moves of over 8% in either direction based on current price levels.

Should You Buy INJ Now? Risk-Reward Analysis

Based on Binance spot market data, the current risk-reward profile for INJ presents distinct opportunities and challenges for different trader types. Conservative investors should exercise extreme caution given the regulatory uncertainties and the token’s position below key moving averages.

For swing traders, the oversold conditions present a potential opportunity, but timing is crucial. A break below $12.15 would likely trigger further selling toward the $11.90 support zone, offering a better entry point. Conversely, a bounce from current levels could target the $13.77 resistance, providing a favorable 9% upside potential.

Day traders should focus on the $12.15-$12.92 range established over the past 24 hours. The narrow trading range combined with elevated volatility readings suggests that a breakout in either direction could provide significant momentum opportunities.

Risk management remains paramount given the regulatory overhang. Stop-losses below $11.80 would protect against a breakdown of the long-term uptrend, while profit targets should be set conservatively near $13.50 given the strong overhead resistance.

Conclusion

The INJ price faces a critical juncture as regulatory pressures clash with oversold technical conditions. While the immediate delisting impact appears to be stabilizing, Injective’s path forward depends heavily on regulatory clarity and the token’s ability to hold key support levels. Traders should monitor the $12.15 support closely over the next 24-48 hours, as a break could trigger further downside toward $11.90. Conversely, a sustained move above $13.00 would signal that the worst of the selling pressure may be behind INJ.

Image source: Shutterstock